Sue Forda is Vice President, Global Regulatory Affairs with Eli Lilly and Company and is responsible for all European and Intercontinental regulatory aspects of Lilly’s current and future products. Sue is also the Managing Director of Lilly’s Research site in the UK.
She trained as a pharmacist and has an MSc in the Economic Evaluation of Healthcare. After completing a PhD in neuropharmacology, she worked as a post-doctoral research fellow at St George's Hospital Medical School, University of London. Before she joined Lilly, she worked for Beecham, subsequently SmithKline Beecham Pharmaceuticals, in their Worldwide Regulatory Affairs Department where she held various positions. She was also, briefly, the UK affiliate’s corporate affairs director.
Sue contributes to a number of regulatory initiatives for the European Federation of Pharmaceutical Industries and Associations (EFPIA).